SA’s biggest private hospital groups have obtained supplies of Indian drug manufacturer Cipla’s cut-price generic version of the coronavirus drug remdesivir, which speeds up recovery in severely ill patients.

However, a question mark hangs over whether state patients will benefit as the company is yet to receive orders from provincial health departments.

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as exclusive Financial Times articles, ProfileData financial data, and digital access to the Sunday Times and Times Select.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00. Got a subscription voucher? Redeem it now